AUDITORY AND VESTIBULAR SCIENCE: Edited by Rodney C. DiazCurrent imaging tools for vestibular schwannomaDang, Linha,∗; Tu, Nathan Chin-yaub,∗; Chan, Eleanor Y.a,bAuthor Information aWayne State University Department of Otolaryngology, Detroit bMichigan Ear Institute, Farmington Hills, Michigan, USA Correspondence to Eleanor Y. Chan, MD, FRCSC, Wayne State University Department of Otolaryngology, Michigan Ear Institute, 30055 Northwestern Hwy #101, Farmington Hills, MI 48334, USA. Tel: +1 248 238 8899; e-mail: firstname.lastname@example.org Current Opinion in Otolaryngology & Head and Neck Surgery: October 2020 - Volume 28 - Issue 5 - p 302-307 doi: 10.1097/MOO.0000000000000647 Buy Metrics Abstract Purpose of review Of the tumors found in the cerebellopontine angle (CPA), vestibular schwannomas are by far the most common. Modern diagnostic imaging enables excellent visualization of the CPA and detection of very small tumors while optimizing patient comfort and time. This review addresses the current imaging tools available for diagnosis of vestibular schwannomas. Recent findings The current gold-standard imaging study for vestibular schwannomas is a gadolinium-enhanced T1-weighted MRI. The yield of this expensive study is only about 3–4% given the low incidence of vestibular schwannomas, thus there is utility in screening with noncontrast T2-weighted MRI, which is a quicker and more economical study. Summary Vestibular schwannomas are best evaluated with gadolinium-enhanced T1-weighted MRI, which can detect tumors as small as 2–3 mm. Recent studies have found that the reported sensitivity and specificity of noncontrast MRI is almost equivalent to that of gadolinium-enhanced T1-weighted MRI. As such, this modality is increasingly being adopted by institutions for both diagnosis and surveillance of vestibular schwannomas and shows promise for broader implementation. Newer protocols, such as FLAIR and DTI may provide additional information and further aid preoperative counseling and surgical planning in the future. Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.